State of Funding Market

NIH SBIR is Back: What to Know and Why Now

NIH SBIR is Back: What to Know and Why Now

A few days ago NIH, CDC, and FDA reissued the full slate of parent announcements that carry small companies from feasibility all the way through commercialization. Solicitations are available now! The next submission date is September 5, 2026 but you can submit...

DoW SBIR Reauthorization – What’s Next?

DoW SBIR Reauthorization – What’s Next?

The SBIR and STTR programs are officially on their way back after a five-month hiatus! This is an exciting time but now is not a time for defense startups to celebrate, it is a time to prepare for the colossal opportunity ahead.What Happened and the Makings of the...

SBIR / STTR Paylines by NIH Institute

SBIR / STTR Paylines by NIH Institute

Understanding SBIR/STTR paylines is essential for assessing your funding chances. This guide breaks down current paylines by NIH Institute—including key insights on the NHLBI payline—to help small businesses navigate impact scores, funding thresholds, and strategic opportunities.

SBIR Reauth Momentum: Be Ready when Congress Closes the Gap

SBIR Reauth Momentum: Be Ready when Congress Closes the Gap

Negotiations are moving from talking points to real legislative text. The biggest issue is the cap per year per company. There is meaningful convergence on Phase III transition and modernization and a new “strategic
breakthrough” pathway would enable Phase II awards up to $30M with 100% matching funds and faster award timelines, for certain agency, company, and product combinations.

SBIR Reauthorization Update & What Now?

SBIR Reauthorization Update & What Now?

The Small Business Innovation Research (SBIR) program remains in limbo as negotiations between key senators have reached an impasse. With no clear timeline for resolution, research teams and startups need to
understand what’s happening and how to move forward strategically.